Dr. Ranjan Prakash Bhandari MD
Hematologist-Oncologist | Hematology & Oncology
100 Welday Ave Steubenville OH, 43953About
Dr. Ranjan Bhandari is a hematologist oncologist practicing in Steubenville, OH. Dr. Bhandari specializes in the diagnosis, treatment and prevention of blood diseases such as anemia, hemophilia, sickle-cell disease, leukemia and lymphoma. Hematologist Oncologists are also trained in the study of cancer and its attack on other organs.
Education and Training
Case Western Reserve University School of Medicine 1980
Indira Gandhi Medical College 1981
University at Buffalo State University of New York School of Medicine & Biomedical Sciences 1990
Provider Details
Treatments
- Anemia
- Breast Cancer
- Lung Cancer
- Colon Cancer
- Lymphoma
- Immunodeficiency
- Deep Vein Thrombosis (dvt)
- Leukemia
- Permanent Removal Of Ingrown Toenails
- Extra Corporeal Shockwave Therapy
Dr. Ranjan Prakash Bhandari MD's Practice location
Dr. Ranjan Prakash Bhandari MD's reviews
Write ReviewPatient Experience with Dr. Bhandari
Recommended Articles
- Woman Who Battled Lymphoma Three Times Starts Support Group
Battling cancer is just that - a battle. To make it through once is an incredible feat, but one Virginia Beach woman survived the terrible condition three times. Now, she is starting a support group so other women can have the incredible outcome she had as well.Lynne's storyUnfortunately, most...
- Tips for Young Adult Lymphoma Survivors to Make the Most of Recovery
It is extremely difficult to reenter the world and normal life after battling lymphoma. Recovery is much more than the body's physical battle, but how to balance emotions and relationships as well.However, there are specific tools that can assist in adapting back into a life that may seem...
- The Promising Future of Gene Therapy and Lymphoma
Non-Hodgkin lymphoma affects over 700,000 people in America alone. Though current treatments are moderately effective, especially for aggressive forms of the disease, more can be done to help people impacted by NHL. Researchers are doing just that by working to develop new, innovative treatment for...
- Astonishing Clinical Trial Results Show Promise for Non-Hodgkin Lymphoma Research
There’s good news for those who’ve been diagnosed with the aggressive non-Hodgkin lymphoma (NHL) type referred to as diffuse large-B cell (DLBCL). According to the American Cancer Society (ACS), this type of HNL is the most common type of lymphoma.The descriptive letters clarify the type of...
- Living with Lymphoma Day by Day
A majority of individuals diagnosed with lymphoma find that they have to make a great deal of adjustments to their lives. There are several physical, emotional, social, and everyday obstacles from diagnosis to remission.Living with lymphoma can be different for every individual, which is why it is...
- How Immunotherapy Makes a Real Difference in Relapsed Hodgkin Lymphoma
Hodgkin lymphoma, which affects about 0.2% of the people in the United States, is often treated using a combination of chemotherapy, radiation therapy, and stem cell transplant. Sometimes these treatments fail to halt the progress of the disease, and in other cases the cancer seems to halt but then...